Yael Hayon - VP, Research & Development at Protalix BioTherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
VP, Research & Development
Stock Symbol
PLX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Yael Hayon since 12/22/2023

Holdings reported by Yael Hayon for Protalix BioTherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 35.1K $49.5K $1.41 Aug 15, 2023 By Trust
Stock Options (Right to Buy) 35.1K Aug 15, 2023 Direct Common Stock

Transactions reported by Yael Hayon for Protalix BioTherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.